US 7,541,035 B2
	Immunogenic peptides for the treatment of prostate and breast cancer
Jay A. Berzofsky, Bethesda, Md. (US); SangKon Oh, Bethesda, Md. (US); and Ira Pastan, Potomac, Md. (US)
Assigned to The United States of America as represented by the Secretary of the Department of Health and Human Services, Washington, D.C. (US)
Appl. No. 10/559,329 PCT Filed Jun. 02, 2004, PCT No. PCT/US2004/017574 § 371(c)(1), (2), (4) Date Dec. 02, 2005, PCT Pub. No. WO2005/000889, PCT Pub. Date Jan. 06, 2005.
Claims priority of provisional application 60/476467, filed on Jun. 05, 2003.
Prior Publication US 2006/0140967 A1, Jun. 29, 2006
Int. Cl. C07K 5/00 (2006.01)

U.S. Cl. 424—185.1  [530/300; 530/350; 435/7.1; 435/7.8; 435/34; 435/320.1; 435/325; 536/23.5; 436/501; 424/277.1]

25 Claims

1. An isolated polypeptide consisting of SEQ ID NO: 6.